Trials / Completed
CompletedNCT01805323
A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone Intravitreal Implant | Dexamethasone Intravitreal Implant (OZURDEX®) previously administered according to general clinical practice. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-04-15
- Completion
- 2013-04-15
- First posted
- 2013-03-06
- Last updated
- 2019-04-17
- Results posted
- 2014-05-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01805323. Inclusion in this directory is not an endorsement.